U.S. Pharmacogenomics Markets Key Alliances and Pro-Active Networking Efforts Essential for Success...
7
U.S. Pharmacogenomics Markets Key Alliances and Pro-Active Networking Efforts Essential for Success "Investors and established companies should begin scouting start-up companies and academic laboratories for innovative technologies." Drug Discovery and Biotechnology Analyst Team Frost & Sullivan
-
Upload
elaine-bishop -
Category
Documents
-
view
213 -
download
1
Transcript of U.S. Pharmacogenomics Markets Key Alliances and Pro-Active Networking Efforts Essential for Success...
U.S. Pharmacogenomics Markets
Key Alliances and Pro-Active Networking Efforts Essential for Success
"Investors and established companies should begin scouting start-up companies and academic laboratories for innovative technologies."
Drug Discovery and Biotechnology Analyst Team
Frost & Sullivan
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analytical insights into current topics and emerging applications in the pharmacogenomics market
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis
Key Features
• Coverage: The United States
• Proven methodology using extensive primary and secondary data as well as research
• Focused information and strategies that cover business and technology issues
• Credible data and analyses that highlight industry dynamics
• Precise strategies to help you create winning business plans
What We Offer
Current Market Participants• Find out where you stand in comparison with the competitors• Assess current and future drivers as well as restraints• Determine and exploit new market share opportunities
New Entrants • Analyze the associated challenges• Calculate timescales for strategy implementation• Position yourself to capitalize on the unmet needs of the market
Investment Community• Analyze long-term strategies of companies • Determine which participants will outperform the competition• Assess the attractiveness of investing in the market
Benefits
Acadia PharmaceuticalsAffymetrix, Inc.AmgenAP BiotechApplera Corp.Arius ResearchArQuleAstraZenecaAventis (USA)Base4, Inc.Bayer (USA)BioMérieuxBioTechnology General Corp.Boehringer Ingelheim (USA)Bristol-Myers Squibb Co.Clontech Laboratories, Inc.CuraGen Corp.
Key Market Participants
Élan (USA)Eli Lilly and Co.EM Industries (USA)ExonHit TherapeuticsFerring Pharmaceuticals, Inc. (USA)Genaissance Pharmaceuticals, Inc.Genentech, Inc.GentaGlaxoSmithKlineHoffmann-La RocheHybrigenicsIncyte PharmaceuticalsInterMune PharmaceuticalsInvitrogen Corp.Lorus Therapeutics, Inc.Matrix Pharmaceuticals, Inc.MDS Ocata, Inc.
MedicisMerckMicroarray CentreMolecular TemplatesNabiNova BiomedicalNovartis (USA)OmniViz, Inc.Ontario Cancer InstituteOrchid BioSciences, Inc.Orphan Australia Pty Ltd.Orphan Europe SARLOrphan Medical, Inc.Orphan PharmaceuticalsOrphan Pharma InternationalPackard Instrument Co.
Key Market Participants (cont’d)
Pierre Fabre SAPfizer Pharmaceuticals GroupPPGx, Inc.Qiagen GenomicsSanofi-Syntélabo (USA)Sequenom, Inc.Shire Pharmaceuticals Group (USA)Sigma-Tau Pharmaceuticals, Inc. (USA)SignalGene, Inc.Swedish OrphanTeva Pharmaceuticals (USA)Therapeutic Goods AdministrationThird Wave TechnologiesTM BioScience Corp.Visible Genetics, Inc.YM Biosciences, Inc.
• Call toll free 877 GO FROST
(877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information
